Which Antiplatelet Agent for Patients With TIA and Obesity? at HealthBulance.

Health care is our expertise. Compared with clopidogrel plus acetylsalicylic acid (ASA), ticagrelor plus ASA is associated with a lower risk for recurrent stroke in patients with obesity who carry the CYP2C19 loss-of-functional allele, new research suggests.

Medscape

Which Antiplatelet Agent for Patients With TIA and Obesity?

Which Antiplatelet Agent for Patients With TIA and Obesity?

Compared with clopidogrel plus acetylsalicylic acid (ASA), ticagrelor plus ASA is associated with a lower risk for recurrent stroke in patients with obesity who carry the CYP2C19 loss-of-functional allele, new research suggests.